Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus Vaccines”

453 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 453 results

Testing effectiveness (Phase 2)Study completedNCT01957878
What this trial is testing

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL

Who this might be right for
Genital Infection ViralHUMAN PAPILLOMA VIRUS
Genticel 239
Post-approval studies (Phase 4)Study completedNCT04590521
What this trial is testing

HPV Vaccine Immunity in High-risk Women

Who this might be right for
HPV Infection
Murdoch Childrens Research Institute 63
Not applicableStudy completedNCT03628885
What this trial is testing

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

Who this might be right for
Human Papilloma Virus VaccinesAttitude to Health
Indiana University 908
Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Large-scale testing (Phase 3)Study completedNCT00652938
What this trial is testing

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 744
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00250276
What this trial is testing

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 798
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Not applicableStudy completedNCT01446718
What this trial is testing

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

Who this might be right for
Human PapillomavirusHIV-1 Infection
Kenya Medical Research Institute 179
Large-scale testing (Phase 3)Active Not RecruitingNCT04255849
What this trial is testing

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaHIV-1-infectionHPV Infection
Weill Medical College of Cornell University 700
Not applicableLooking for participantsNCT06831929
What this trial is testing

HPV Ends Here: Increasing Uptake of the HPV Vaccine

Who this might be right for
HPV Vaccine
University of California, Davis 2,232
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Post-approval studies (Phase 4)Study completedNCT06588257
What this trial is testing

Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study

Who this might be right for
HPV
Fundación Huésped 101
Not applicableStudy completedNCT02456077
What this trial is testing

Strengthening Physician Communication About HPV Vaccines

Who this might be right for
HPV Immunization Status
University of Colorado, Denver 93,582
Large-scale testing (Phase 3)Study completedNCT02750202
What this trial is testing

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Who this might be right for
Genital Warts
University of Pretoria 52
Not applicableEnded earlyNCT02508701
What this trial is testing

A Pilot Study Comparing the Effectiveness of Campus Intervention to Increase HPV Vaccine Rate Among College Aged Men

Who this might be right for
Human Papilloma Virus, Male
Purdue University 24
Large-scale testing (Phase 3)Study completedNCT01651949
What this trial is testing

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Who this might be right for
Genital WartsAnal CancerAnal Intraepithelial Neoplasia
Merck Sharp & Dohme LLC 2,520
Testing effectiveness (Phase 2)Study completedNCT00693615
What this trial is testing

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Looking for participantsNCT07377656
What this trial is testing

Strengthening HPV Immunization Through EPI Leveraged Delivery

Who this might be right for
HPV Vaccine
International Vaccine Institute 115
Next Page